

Cover Story
By Matthew Bin Han Ong
Directors of NCI-designated cancer centers are facing a new set of challenges in a polarizing, high-stakes election year.
In Brief


Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for June 2024
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- NIH Director Jay Bhattacharya launches a podcast
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- “Forward funding” NIH budget plan would make competing for grants much harder
- Optimizing dosing of expensive and toxic oncology drugs: Making America healthier